L
Leif C. Andersson
Researcher at University of Helsinki
Publications - 354
Citations - 17404
Leif C. Andersson is an academic researcher from University of Helsinki. The author has contributed to research in topics: Ornithine decarboxylase & Cell culture. The author has an hindex of 66, co-authored 352 publications receiving 16831 citations. Previous affiliations of Leif C. Andersson include Karolinska Institutet & University of Oulu.
Papers
More filters
Journal ArticleDOI
Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
Heikki Joensuu,Peter J. Roberts,Maarit Sarlomo-Rikala,Leif C. Andersson,Pekka Tervahartiala,David A. Tuveson,David A. Tuveson,Sandra Silberman,Renaud Capdeville,Sasa Dimitrijevic,Brian J. Druker,George D. Demetri +11 more
TL;DR: Gastrointestinal stromal tumors are a group of mesenchymal neoplasms that arise from precursors of the connective-tissue cells of the gastrointestinal tract that occur predominantly in middle-aged and older persons.
Journal ArticleDOI
Ornithine decarboxylase activity is critical for cell transformation.
TL;DR: The results imply that the gene encoding ornithine decarboxylase is a proto-oncogene central for regulation of cell growth and transformation.
Journal ArticleDOI
Selective radioactive labeling of cell surface sialoglycoproteins by periodate-tritiated borohydride.
TL;DR: This simple method of specifically introducing a radioactive label into cell surface sialic acids is useful in the study of cell surfaceSialic acid-containing glycoproteins.
Journal ArticleDOI
K562--a human erythroleukemic cell line.
TL;DR: The K562 cell expressed the major red cell sialoglycoprotein, glycophorin, on its surface as shown by immuno‐fluorescence and by immuneprecipitation from labelled membrane preparations, and it is concluded that the K562 is a human erythroleukemic line.
Journal ArticleDOI
A role for estrogen receptor β in the regulation of growth of the ventral prostate
Zhang Weihua,Sari Mäkelä,Sari Mäkelä,Leif C. Andersson,Leif C. Andersson,Saija Salmi,Shigehira Saji,Jeanette I Webster,Elwood V. Jensen,Stefan K. Nilsson,Margaret Warner,Jan-Ake Gustafsson +11 more
TL;DR: Findings suggest that ligands specific for ERβ may be useful in the prevention and/or clinical management of prostatic hyperplasia and neoplasia.